Cellply is a biology-focused deep tech company based in Bologna, Italy, specializing in biotechnology research. It develops advanced analytical tools and end-to-end single cell potency solutions to study cellular functions.
Subscribe to see Cellply’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Cellply is a biotechnology company headquartered in Italy. It has raised at least $3.9M across the 2 funding rounds on record, 1 of them with a disclosed amount. Its most recent funding round, Series A, closed in September 2023. Xcout tracks 13 named people at Cellply, including Alessia Zanelli (President and Chief Executive Officer).
7 more named people on record for Cellply, with roles, board committees and tenure — see the full roster →
At least $3.9M raised across the 2 rounds on record (1 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | Undisclosed | 1 named | |
| internal round | $3.9M | 3 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.